BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23613188)

  • 1. Nuchal translucency measurement: are qualitative and quantitative quality control processes related?
    Hermann M; Fries N; Mangione R; Boukobza P; Ville Y; Salomon LJ
    Prenat Diagn; 2013 Aug; 33(8):770-4. PubMed ID: 23613188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Likelihood ratio-based quality control for nuchal translucency measurements at 11-14 weeks of gestation.
    Salomon LJ; Porcher R; Stirnemann JJ; Bernard JP; Ville Y
    Ultrasound Obstet Gynecol; 2011 May; 37(5):576-81. PubMed ID: 20814879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuchal Translucency Quality Review (NTQR) program: first one and half million results.
    Cuckle H; Platt LD; Thornburg LL; Bromley B; Fuchs K; Abuhamad A; Benacerraf B; Copel JA; Depp R; D'Alton M; Goldberg J; O'Keeffe D; Spitz J; Toland G; Wapner R;
    Ultrasound Obstet Gynecol; 2015 Feb; 45(2):199-204. PubMed ID: 24753079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of nuchal translucency measurements in The Netherlands: a quantitative analysis.
    Koster MP; Wortelboer EJ; Engels MA; Stoutenbeek PH; Elvers LH; Visser GH; Schielen PC
    Ultrasound Obstet Gynecol; 2009 Aug; 34(2):136-41. PubMed ID: 19562664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualization of intracranial translucency at the 11-13-week scan is improved after specific training.
    Mangione R; Lelong N; Fontanges M; Amat S; Rosenblatt J; Khoshnood B; Jouannic JM
    Ultrasound Obstet Gynecol; 2011 Dec; 38(6):635-9. PubMed ID: 21998023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance of nuchal translucency for prenatal fetal Down syndrome screening.
    Sahota DS; Leung WC; To WK; Chan WP; Lau TK; Leung TY
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1039-43. PubMed ID: 21854135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of sonographer nuchal translucency measurement performance--central tendency and dispersion.
    Sahota DS; Chen M; Leung TY; Chan LW; Fung TY; Ting YH; Lau TK
    J Matern Fetal Neonatal Med; 2011 Jun; 24(6):812-6. PubMed ID: 21265719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonologist's characteristics related to a higher quality in fetal nuchal translucency measured in primary antenatal care centers.
    Torrent A; Manrique G; Gómez-Castelló T; Baldrich E; Cahuana M; Manresa JM; Borrell A
    Prenat Diagn; 2019 Sep; 39(10):934-939. PubMed ID: 31237971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture.
    Sahota DS; Leung TY; Chen M; Chan LW; Fung TY; Lau TK
    Ultrasound Obstet Gynecol; 2010 Jul; 36(1):15-9. PubMed ID: 20503228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A simple self-assessment tool for the first-trimester ultrasound images].
    Dhombres F; Friszer S; Bessis R; Jouannic JM
    Gynecol Obstet Fertil; 2015 Dec; 43(12):761-6. PubMed ID: 26476892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. United States' experience in nuchal translucency measurement: variation according to provider characteristics in over five million ultrasound examinations.
    Thornburg LL; Bromley B; Dugoff L; Platt LD; Fuchs KM; Norton ME; McIntosh J; Toland GJ; Cuckle H;
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):732-737. PubMed ID: 33634915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
    D'Alton ME; Cleary-Goldman J; Lambert-Messerlian G; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor IE; Carr SR; Wolfe HM; Dukes K; Canick JA; Malone FD
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):142-6. PubMed ID: 19173241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a shift in nuchal translucency measurements on the detection rate of first-trimester Down syndrome screening: A population-based study.
    Fries N; Salomon LJ; Muller F; Dreux S; Houfflin-Debarge V; Coquel P; Kleinfinger P; Dommergues M;
    Prenat Diagn; 2018 Jan; 38(2):106-109. PubMed ID: 29231978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formative assessment based on an audit and feedback improves nuchal translucency ultrasound image quality.
    Chalouhi GE; Salomon LJ; Fontanges M; Althuser M; Haddad G; Scemama O; Chabot JM; Duyme M; Fries N
    J Ultrasound Med; 2013 Sep; 32(9):1601-5. PubMed ID: 23980221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
    Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between nuchal translucency and nuchal skin-fold measurements in Down syndrome and unaffected fetuses.
    Maymon R; Zimerman AL; Weinraub Z; Herman A; Cuckle H
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):501-5. PubMed ID: 18512852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperator and interoperator repeatability of manual and semi-automated measurement of increased fetal nuchal translucency according to the operator's experience.
    Kagan KO; Abele H; Yazdi B; Böer B; Pintoffl K; Wright D; Hoopmann M
    Prenat Diagn; 2011 Dec; 31(13):1229-33. PubMed ID: 22024964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditing ultrasound assessment of fetal nuchal translucency thickness: a review of Australian National Data 2002-2008.
    Nisbet DL; Robertson AC; Schluter PJ; McLennan AC; Hyett JA
    Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):450-5. PubMed ID: 21039379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance.
    Evans MI; Krantz DA; Hallahan TW; Sherwin J
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):181-4. PubMed ID: 21484907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuchal translucency-based Down syndrome screening: barriers to implementation.
    Malone FD
    Semin Perinatol; 2005 Aug; 29(4):272-6. PubMed ID: 16104681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.